Permanent activation of HMGA2 in lipomas mimics its temporal physiological activation linked to the gain of adipose tissue

Obesity

Volumn 22, Issue 1, 2014, Pages 141-150

  Thies, Helge W ^a   Nolte, Ingo ^b   Wenk, Heiner ^c   Mertens, Fredrik ^d   Bullerdiek, Jörn ^a,b   Markowski, Dominique N ^a  

^a UNIVERSITY OF BREMEN   (Germany)

^b UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^c Clinical Center Bremen Nord   (Germany)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; FIBROBLAST GROWTH FACTOR 1; HIGH MOBILITY GROUP A2 PROTEIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ABDOMINAL SUBCUTANEOUS FAT; ADIPOGENESIS; ADIPOSE TISSUE CELL; ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; DOG; FEMALE; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC CORRELATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPOMA; MALE; MOLECULAR PATHOLOGY; NONHUMAN; OBESITY; STEM CELL; WEIGHT GAIN; WHITE ADIPOSE TISSUE;

CANIS FAMILIARIS;

ADIPOGENESIS; ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOGS; FEMALE; FIBROBLAST GROWTH FACTOR 1; GENE REARRANGEMENT; HMGA2 PROTEIN; HUMANS; LIPOMA; MALE; OVERWEIGHT; PPAR GAMMA; RNA INTERFERENCE; RNA, MESSENGER; STEM CELLS; SUBCUTANEOUS FAT, ABDOMINAL; TUMOR SUPPRESSOR PROTEIN P14ARF; UP-REGULATION;

EID: 84892371029     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20137     Document Type: Article

References (27)

1. Ashar HR, Fejzo MS, Tkachenko A, et al. Disruption of the architectural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains. Cell 1995; 82: 57-65.
2. Schoenmakers EF, Wanschura S, Mols R, Bullerdiek J, Van den Berghe H, Van de Ven WJ,. Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumors. Nat Genet 1995; 10: 436-444.
3. Bartuma H, Panagopoulos I, Collin A, et al. Expression levels of HMGA2 in adipocytic tumors correlate with morphologic and cytogenetic subgroups. Mol Cancer 2009; 8: 36.
4. Tallini G, Dal Cin P, Rhoden KJ, et al. Expression of HMGI-C and HMGI(Y) in ordinary lipoma and atypical lipomatous tumors: immunohistochemical reactivity correlates with karyotypic alterations. Am J Pathol 1997; 1: 37-43.
5. Battista S, Fidanza V, Fedele M, et al. The expression of a truncated HMGI-C gene induces gigantism associated with lipomatosis. Cancer Res 1999; 59: 4793-4797.
6. Zhou X, Benson KF, Ashar HR, Chada K,. Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C. Nature 1995; 376: 771-774.
7. Pasquali D, Pierantoni GM, Fusco A, et al. Fenofibrate increases the expression of high mobility group AT-hook 2 (HMGA2) gene and induces adipocyte differentiation of orbital fibroblasts from Graves' ophthalmopathy. J Mol Endocrinol 2004; 33: 133-143.
8. Rogalla P, Drechsler K, Frey G, et al. HMGI-C expression patterns in human tissues. Implications for the genesis of frequent mesenchymal tumors. Am J Pathol 1996; 3: 775-779.
9. Spalding KL, Arner E, Westermark PO, et al. Dynamics of fat cell turnover in humans. Nature 2008; 453: 783-787.
10. Hutley L, Shurety W, Newell F, et al. Fibroblast growth factor 1: a key regulator of human adipogenesis. Diabetes 2004; 53: 3097-3106.
11. Newell FS, Su H, Tornqvist H, Whitehead JP, Prins JB, Hutley LJ,. Characterization of the transcriptional and functional effects of fibroblast growth factor-1 on human preadipocyte differentiation. FASEB J 2006; 20: 2615-2617.
12. Widberg CH, Newell FS, Bachmann AW, et al. Fibroblast growth factor receptor 1 is a key regulator of early adipogenic events in human preadipocytes. Am J Physiol Endocrinol Metab 2009; 296: E121-E131.
13. Sutter NB, Ostrander EA,. Dog star rising: the canine genetic system. Nat Rev Genet 2004; 5: 900-910.
14. Planat-Bénard V, Menard C, André M, et al. Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells. Circ Res 2003; 94: 223-229.
15. Markowski DN, von Ahsen I, Nezhad MH, Wosniok W, Helmke BM, Bullerdiek J,. HMGA2 and the p19Arf-TP53-CDKN1A axis: a delicate balance in the growth of uterine leiomyomas. Genes Chromosomes Cancer 2010; 49: 661-668.
16. Gorzelniak K, Janke J, Engeli S, Sharma AM,. Validation of endogenous controls for gene expression studies in human adipocytes and preadipocytes. Horm Metab Res 2001; 33: 625-627.
17. Schmitz S,. Hunderassen. Wie sie sind-Wie man sie hält, 2nd ed. München, Germany, BLV; 2003.
18. Ayoubi TA, Jansen E, Meulemans SM, Van de Ven WJ,. Regulation of HMGIC expression: an architectural transcription factor involved in growth control and development. Oncogene 1999; 18: 5076-5087.
19. Markowski DN, Winter N, Meyer F, et al. p14Arf acts as an antagonist of HMGA2 in senescence of mesenchymal stem cells-implications for benign tumorigenesis. Genes Chromosomes Cancer 2011; 50: 489-498.
20. Kubota N, Terauchi Y, Miki H, et al. PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell 1999; 4: 597-609.
21. Bartuma H, Hallor KH, Panagopoulos I, et al. Assessment of the clinical and molecular impact of different cytogenetic subgroups in a series of 272 lipomas with abnormal karyotype. Genes Chromosomes Cancer 2007; 46: 594-606.
22. Tang W, Zeve D, Suh JM, et al. White fat progenitor cells reside in the adipose vasculature. Science 2008; 322: 583-586.
23. Tchoukalova YD, Votruba SB, Tchkonia T, Giorgadze N, Kirkland JL, Jensen MD,. Regional differences in cellular mechanisms of adipose tissue gain with overfeeding. Proc Natl Acad Sci USA 2010; 42: 18226-18231.
24. Benson KF, Chada K,. Mini-mouse: phenotypic characterization of a transgenic insertional mutant allelic to pygmy. Genet Res 1994; 64: 27-33.
25. Anand A, Chada K,. In vivo modulation of Hmgic reduces obesity. Nat Genet 2000; 24: 377-380.
26. Lowell BB,. PPARgamma: an essential regulator of adipogenesis and modulator of fat cell function. Cell 1999; 99: 239-242.
27. Lee EK, Lee MJ, Abdelmohsen K, et al. miR-130 suppresses adipogenesis by inhibiting peroxisome proliferator-activated receptor gamma expression. Mol Cell Biol 2011; 31: 626-638.